so the regulatory T cells do not act anywhere else in the body, because they are lymphocytes of that person and do not attacch to the self cells and tissue, but only bind to and protect from immune attack the transplanted kidney cells with the different haplotype.
i think thiis is really gonna be significant for SGMO, but you know that already since i have been boosting the TxCell aquisition for over a year there. i do think it will be a big part of SGMO in the future, and what makes them such an attractive target for a major pharma, imo.
i think this was what Sandy was thinking wwhen he hired JDFontenot who is so famous for his work on how the Treg consumes IL-2 but cnot produce it. i had posted up his research back then. and I also talked about Megan Levings too. her work on Tregs.